An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity by Ioanna Barla, Panagiotis Efentakis, Sofia Lamprou, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Evangelos Terpos, Ioanna Andreadou, Nikolaos Thomaidis, Evangelos Gikas

Subjects: “…carfilzomib…”
Get full text

Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma by Liping Liu, Ningning Zhao, Wenjun Xu, Zhixin Sheng, Lida Wang

Subjects: “…Carfilzomib…”
Get full text

Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma by Bhutani D, Zonder JA

Subjects: Get full text

Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21Waf1/Cip1 and p27Kip1 by Yuanyuan Zhou, Ke Wang, Shuai Zhen, Ruili Wang, Wenjuan Luo

Subjects: “…carfilzomib…”
Get full text

Carfilzomib for relapsed and refractory multiple myeloma by Groen K, van de Donk NWCJ, Stege CAM, Zweegman S, Nijhof IS

Subjects: Get full text

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits by Diego Acosta-Alvear, Min Y Cho, Thomas Wild, Tonia J Buchholz, Alana G Lerner, Olga Simakova, Jamie Hahn, Neha Korde, Ola Landgren, Irina Maric, Chunaram Choudhary, Peter Walter, Jonathan S Weissman, Martin Kampmann

Subjects: Get full text

Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway by Faisal Imam, Muhammad Afzal, Nehmat Ghaboura, Khalid Saad Alharbi, Imran Kazmi, Samiyah Alshehri, Sana Saeed Alqarni, Emine Guven

Subjects: Get full text

Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib‐based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group... by Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, Ayako Muramatsu, Hitoji Uchiyama, Nana Sasaki, Nobuhiko Uoshima, Mitsushige Nakao, Ryoichi Takahashi, Kazuho Shimura, Hiroto Kaneko, Miki Kiyota, Katsuya Wada, Yoshiaki Chinen, Koichi Hirakawa, Shin‐ichi Fuchida, Chihiro Shimazaki, Yayoi Matsumura‐Kimoto, Shinsuke Mizutani, Taku Tsukamoto, Yuji Shimura, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda, Kyoto Clinical Hematology Study Group (KOTOSG) Investigators

Subjects: Get full text

The use of carfilzomib to treat extramedullary plasmacytoma and review of the literature by Figen Atalay

Subjects: “…carfilzomib…”
Get full text

Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database by Arleigh McCurdy, Martha Louzada, Christopher P. Venner, Alissa Visram, Esther Masih‐Khan, Moustafa Kardjadj, Victor H. Jimenez‐Zepeda, Richard LeBlanc, Michael Sebag, Kevin Song, Darrell White, Hira Mian, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Rami Kotb, Engin Gul, Donna Reece

Subjects: “…carfilzomib…”
Get full text

Using protein turnover assay to explore the drug mechanism of Carfilzomib by Tao Yonghui, Ding Xinyu, Jia Caiwei, Wang Chengcheng, Li Chuanyin

Subjects: “…Carfilzomib…”
Get full text

Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review by Federica Pallotti, Claire Queffeulou, Mathieu Bellal, Bastien Jean-Jacques, Anne-Claire Gac, Valérie Chatelet, Annabel Boyer, Victor Gueutin

Subjects: “…carfilzomib…”
Get full text

QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross‐sectional... by Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Niklas Zojer, Laurenz Schöffmann, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria‐Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl‐Spandl, Hermine Agis, Michael Fillitz, Song‐Yau Wang, Stefan Knop, Richard Greil

Subjects: “…carfilzomib…”
Get full text

Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database by Arleigh McCurdy, Christopher P. Venner, Esther Masih-Khan, Martha Louzada, Richard LeBlanc, Michael Sebag, Kevin Song, Victor H. Jimenez-Zepeda, Rami Kotb, Moustafa Kardjadj, Hira Mian, Darrell White, Julie Stakiw, Muhammad Aslam, Anthony Reiman, Engin Gul, Donna Reece

Subjects: Get full text

Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis by Marwa Tantawy, Lakshmi Manasa Chekka, Yimei Huang, Timothy J. Garrett, Sonal Singh, Chintan P. Shah, Robert F. Cornell, Rachid C. Baz, Michael G. Fradley, Nida Waheed, David L. DeRemer, Lihui Yuan, Taimour Langaee, Taimour Langaee, Keith March, Carl J. Pepine, Jan S. Moreb, Yan Gong, Yan Gong, Yan Gong

Subjects: Get full text

Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug by Grazia Raffaella Tundo, Diego Sbardella, Francesco Oddone, Giuseppe Grasso, Stefano Marini, Maria Grazia Atzori, Anna Maria Santoro, Danilo Milardi, Francesco Bellia, Gabriele Macari, Grazia Graziani, Fabio Polticelli, Paolo Cascio, Mariacristina Parravano, Massimo Coletta

Subjects: Get full text

New proteasome inhibitors in the management of multiple myeloma by S. V. Semochkin

Subjects: Get full text

Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review by Jianchao Wang, Wensheng Liao, Zhongwen Liu, Dai Kong

Subjects: Get full text

Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells by Marta Pelon, Patryk Krzeminski, Zuzanna Tracz-Gaszewska, Irena Misiewicz-Krzeminska

Subjects: Get full text

Pilot Study: Quantitative Photoacoustic Evaluation of Peripheral Vascular Dynamics Induced by Carfilzomib In Vivo by Thi Thao Mai, Manh-Cuong Vo, Tan-Huy Chu, Jin Young Kim, Chulhong Kim, Je-Jung Lee, Sung-Hoon Jung, Changho Lee

Subjects: “…carfilzomib…”
Get full text